Activation of invariant natural killer T cells by alpha-galactosylceramide ameliorates doxorubicin-induced cardiotoxicity in mice

Yoshikuni Obata; Naoki Ishimori; Akimichi Saito; Shintaro Kinugawa; Takashi Yokota; Shingo Takada; Ippei Nakano; Naoya Kakutani; Katsuma Yamanashi; Toshihisa Anzai

doi:10.1177/2047487319901208

Activation of invariant natural killer T cells by alpha-galactosylceramide ameliorates doxorubicin-induced cardiotoxicity in mice

Yoshikuni Obata, Naoki Ishimori, Akimichi Saito, Shintaro Kinugawa, Takashi Yokota, Shingo Takada, Ippei Nakano, Naoya Kakutani, Katsuma Yamanashi, Toshihisa Anzai

研究成果: ジャーナルへの寄稿 › 学術誌 › 査読

3 被引用数 (Scopus)

本文言語	英語
ページ（範囲）	2358-2361
ページ数	4
ジャーナル	European Journal of Preventive Cardiology
巻	27
号	19
DOI	https://doi.org/10.1177/2047487319901208
出版ステータス	出版済み - 12月 2020
外部発表	はい

!!!All Science Journal Classification (ASJC) codes

疫学
循環器および心血管医学

文献へのアクセス

10.1177/2047487319901208

他のファイルとリンク

引用スタイル

Obata, Y, Ishimori, N, Saito, A, Kinugawa, S, Yokota, T, Takada, S, Nakano, I, Kakutani, N, Yamanashi, K & Anzai, T 2020, 'Activation of invariant natural killer T cells by alpha-galactosylceramide ameliorates doxorubicin-induced cardiotoxicity in mice', European Journal of Preventive Cardiology, vol. 27, no. 19, pp. 2358-2361. https://doi.org/10.1177/2047487319901208

@article{457acbf81caf4bf9bc12fcb3b1f657e3,

title = "Activation of invariant natural killer T cells by alpha-galactosylceramide ameliorates doxorubicin-induced cardiotoxicity in mice",

author = "Yoshikuni Obata and Naoki Ishimori and Akimichi Saito and Shintaro Kinugawa and Takashi Yokota and Shingo Takada and Ippei Nakano and Naoya Kakutani and Katsuma Yamanashi and Toshihisa Anzai",

note = "Funding Information: We thank Miwako Yamane and Yuki Kimura for their excellent technical assistance. The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: this work was supported, in part, by grants from the Japan Agency for Medical Research and Development (The Translational Research programs 17lm0203001j0001 and 18lm0203001j0002 to Dr Ishimori) and the Japan Society for the Promotion of Science (KAKENHI grant number JP18K15834 to Dr Saito).",

year = "2020",

month = dec,

doi = "10.1177/2047487319901208",

language = "English",

volume = "27",

pages = "2358--2361",

journal = "European Journal of Preventive Cardiology",

issn = "2047-4873",

publisher = "SAGE Publications Ltd",

number = "19",

}

TY - JOUR

T1 - Activation of invariant natural killer T cells by alpha-galactosylceramide ameliorates doxorubicin-induced cardiotoxicity in mice

AU - Obata, Yoshikuni

AU - Ishimori, Naoki

AU - Saito, Akimichi

AU - Kinugawa, Shintaro

AU - Yokota, Takashi

AU - Takada, Shingo

AU - Nakano, Ippei

AU - Kakutani, Naoya

AU - Yamanashi, Katsuma

AU - Anzai, Toshihisa

N1 - Funding Information: We thank Miwako Yamane and Yuki Kimura for their excellent technical assistance. The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: this work was supported, in part, by grants from the Japan Agency for Medical Research and Development (The Translational Research programs 17lm0203001j0001 and 18lm0203001j0002 to Dr Ishimori) and the Japan Society for the Promotion of Science (KAKENHI grant number JP18K15834 to Dr Saito).

PY - 2020/12

Y1 - 2020/12

UR - http://www.scopus.com/inward/record.url?scp=85081654271&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85081654271&partnerID=8YFLogxK

U2 - 10.1177/2047487319901208

DO - 10.1177/2047487319901208

M3 - Article

C2 - 32122197

AN - SCOPUS:85081654271

SN - 2047-4873

VL - 27

SP - 2358

EP - 2361

JO - European Journal of Preventive Cardiology

JF - European Journal of Preventive Cardiology

IS - 19

ER -